Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies: The SEARCH-AF study
The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Abstract
Atrial fibrillation (AF) causes a third of all strokes, but often goes undetected before stroke. Identification of unknown AF in the community and subsequent anti-thrombotic treatment could reduce stroke burden. We investigated community screening for unknown AF using an iPhone electrocardiogram (iECG) in pharmacies, and determined the cost-effectiveness of this strategy.Pharmacists performedpulse palpation and iECG recordings, with cardiologist iECG over-reading. General practitioner review/12-lead ECG was facilitated for suspected new AF. An automated AF algorithm was retrospectively applied to collected iECGs. Cost-effectiveness analysis incorporated costs of iECG screening, and treatment/outcome data from a United Kingdom cohort of 5,555 patients with incidentally detected asymptomatic AF. A total of 1,000 pharmacy customers aged ≥65 years (mean 76 ± 7 years; 44% male) were screened. Newly identified AF was found in 1.5% (95% CI, 0.8-2.5%); mean age 79 ± 6 years; all had CHA2DS2-VASc score ≥2. AF prevalence was 6.7% (67/1,000). The automated iECG algorithm showed 98.5% (CI, 92-100%) sensitivity for AF detection and 91.4% (CI, 89-93%) specificity. The incremental cost-effectiveness ratio of extending iECG screening into the community, based on 55% warfarin prescription adherence, would be $AUD5,988 (€3,142; $USD4,066) per Quality Adjusted Life Year gained and $AUD30,481 (€15,993; $USD20,695) for preventing one stroke. Sensitivity analysis indicated cost-effectiveness impro…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several patientoperated devices 136,137 and extended continuous ECG monitoring using skin patch recorders 138 have been validated for detection of paroxysmal AF. 139”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [139]
In the citing paper
“Similar accuracy estimates were obtained in a study by Lowers and colleagues (sensitivity of 98.5% and specificity of 91.4%).10”
From Portable out-of-hospital electrocardiography: A review of current technologies (2018) · cites this paper as [10]
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215 · cited 1×
“Our cost-effectiveness analysis assumed non-inferiority for NOACs vs warfarin, which may be clinically conservative (27, 28), and therefore may be an underestimate of the possible net clinical benefit for stroke and major bleeds from use of NOACs (29).”
MethodApixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Edoxaban versus warfarin in patients with atrial fibrillation
Giugliano, R. P., Ruff, C. T., Braunwald, E., Murphy, S. A., Wiviott, S. D., Halperin, J. L., Waldo, A. L., Ezekowitz, M. D., Weitz, J. I., Špinar, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310907 · Cited by 5,164
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,822
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs253 · Cited by 2,899
Subclinical atrial fibrillation and the risk of stroke
Healey, J. S., Connolly, S. J., Gold, M. R., Israel, C. W., Van Gelder, I. C., Capucci, A., Lau, C. P., Fain, E., Yang, S., Bailleul, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105575 · Cited by 2,100 · cited 1×
“Because asymptomatic AF is common (4) and those with undiagnosed asymptomatic AF are at increased risk of sustaining a stroke prior to AF detection (5, 6), practical approaches are required for widespread early detection.”
BackgroundMarini, C., De Santis, F., Sacco, S., Russo, T., Olivieri, L., Totaro, R., & Carolei, A. (2005) · Stroke · doi:10.1161/01.str.0000166053.83476.4a · Cited by 949
Ovbiagele, B., Goldstein, L. B., Higashida, R. T., Howard, V. J., Johnston, S. C., Khavjou, O. A., Lackland, D. T., Lichtman, J. H., Mohl, S., Sacco, R. L., et al. (2013) · Stroke · doi:10.1161/str.0b013e31829734f2 · Cited by 834
National Institute for Clinical Excellence and its value judgments
Rawlins, M. D., & Culyer, A. J. (2004) · BMJ · doi:10.1136/bmj.329.7459.224 · Cited by 765
Acute Stroke With Atrial Fibrillation: The Copenhagen Stroke Study
Jørgensen, H. S., Nakayama, H., Reith, J., Raaschou, H. O., & Olsen, T. S. (1996) · Stroke · doi:10.1161/01.str.27.10.1765 · Cited by 522
Hobbs, F., Fitzmaurice, D., Mant, J., Murray, E., Jowett, S., Bryan, S., Raftery, J., Davies, M., & Lip, G. (2005) · Health Technology Assessment · doi:10.3310/hta9400 · Cited by 437
Atrial Fibrillation, Stroke Risk, and Warfarin Therapy Revisited: A Population-Based Study
Björck, S., Palaszewski, B., Friberg, L., & Bergfeldt, L. (2013) · Stroke · doi:10.1161/strokeaha.113.002329 · Cited by 334
Screening to identify unknown atrial fibrillation: A systematic review
Lowres, N., Neubeck, L., Redfern, J., & Freedman, S. B. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-02-0165 · Cited by 327
Self-citationLau, J. K., Lowres, N., Neubeck, L., Brieger, D. B., Sy, R. W., Galloway, C. D., Albert, D. E., & Freedman, S. B. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.220 · Cited by 326
Self-citationKimura, K. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.048827 · Cited by 321
Anderson, J. L., Halperin, J. L., Albert, N. M., Bozkurt, B., Brindis, R. G., Curtis, L. H., DeMets, D., Guyton, R. A., Hochman, J. S., Kovacs, R. J., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.001 · Cited by 311
Banerjee, A., Lane, D. A., Torp-Pedersen, C., & Lip, G. Y. H. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-11-0784 · Cited by 301
Sex Differences in Stroke Risk Among Older Patients With Recently Diagnosed Atrial Fibrillation
Jackevicius, C. A. (2012) · JAMA · doi:10.1001/jama.2012.3490 · Cited by 241
Engdahl, J., Andersson, L., Mirskaya, M., & Rosenqvist, M. (2013) · Circulation · doi:10.1161/circulationaha.112.126656 · Cited by 233
Pink, J., Lane, S., Pirmohamed, M., & Hughes, D. A. (2011) · BMJ · doi:10.1136/bmj.d6333 · Cited by 216
Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines, C., Bax, J. J., et al. (2012) · doi:10.48350/15016 · Cited by 206
Anderson, J. L., Halperin, J. L., Albert, N. M., Bozkurt, B., Brindis, R. G., Curtis, L. H., DeMets, D., Guyton, R. A., Hochman, J. S., Kovacs, R. J., et al. (2013) · Circulation · doi:10.1161/cir.0b013e318290826d · Cited by 172
Lip, G. Y. H., Kamath, S., Jafri, M., Mohammed, A., & Bareford, D. (2002) · Stroke · doi:10.1161/hs0102.101817 · Cited by 168
Community pharmacy in Australia
Benrimoj, S. I., & Frommer, M. S. (2004) · Australian Health Review · doi:10.1071/ah040238 · Cited by 158
Zalesak, M., Siu, K., Francis, K., Yu, C., Alvrtsyan, H., Rao, Y., Walker, D., Sander, S., Miyasato, G., Matchar, D., et al. (2013) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000192 · Cited by 151
Adelaide Stroke Incidence Study: Declining Stroke Rates but Many Preventable Cardioembolic Strokes
Leyden, J. M., Kleinig, T. J., Newbury, J., Castle, S., Cranefield, J., Anderson, C. S., Crotty, M., Whitford, D., Jannes, J., Lee, A., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.675140 · Cited by 140
Evaluation of patients’ attitudes towards stroke prevention and bleeding risk in atrial fibrillation
Regpala, S., Lacombe, S., Sharma, M., Gibbens, S., Ball, D., Francis, K., & LaHaye, S. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-05-0424 · Cited by 130
Aliot, E., Breithardt, G., Brugada, J., Camm, J., Lip, G. Y. H., Vardas, P. E., Wagner, M., & for the Atrial Fibrillation AWareness And Risk Education (AF AWARE) group [comprising the Atrial Fibrillation Association (AFA), T. E. H. R. A. (. (2010) · Europace · doi:10.1093/europace/euq109 · Cited by 119
Finfer, S. R. (2006) · Journal of the Japan Society of Blood Transfusion · doi:10.3925/jjtc1958.52.19 · Cited by 111
Statistical approaches to handling uncertainty in health economic evaluation
Briggs, A. H. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200406000-00007 · Cited by 78
Krass, I., Mitchell, B., Clarke, P., Brillant, M., Dienaar, R., Hughes, J., Lau, P. M.-Y., Peterson, G. M., Stewart, K., Taylor, S. E., et al. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.06.022 · Cited by 70
Self-citationCadilhac, D. A., Dewey, H. M., Vos, T., Carter, R., & Thrift, A. G. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-49 · Cited by 70
Lip, G. Y. H., & Lane, D. A. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-01-0063 · Cited by 68
Chlamydia testing in community pharmacies: evaluation of a feasibility pilot in south east London
Baraitser, P., Pearce, V., Holmes, J., Horne, N., & Boynton, P. (2007) · BMJ Quality & Safety · doi:10.1136/qshc.2006.020883 · Cited by 61
Effectiveness of systematic screening for the detection of atrial fibrillation
Moran, P. S., Flattery, M. J., Teljeur, C., Ryan, M., & Smith, S. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009586.pub2 · Cited by 60
Pisters, R., Nieuwlaat, R., Lane, D. A., Crijns, H. J. G. M., & Lip, G. Y. H. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-08-0539 · Cited by 57
Sharma, M., Bradley-Kennedy, C., Clemens, A., Monz, B. U., Peng, S., Roskell, N., Sorensen, S. V., & Kansal, A. R. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0388 · Cited by 56
Barriers to Warfarin Use for Stroke Prevention in Patients With Atrial Fibrillation in Hong Kong
Lee, V. W. Y., Tam, C. S., Yan, B. P., Yu, C., & Lam, Y. Y. (2012) · Clinical Cardiology · doi:10.1002/clc.22077 · Cited by 39
Stott, D. J., Dewar, R., Garratt, C. J., Griffith, K., Harding, N., James, M. A., Lane, D. A., Petty, D., Smith, P., Somerville, M., et al. (2012) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2012.s01 · Cited by 38
Claes, N., Van Laethem, C., Goethals, M., Goethals, P., Mairesse, G., Schwagten, B., Nuyens, D., Schrooten, W., & Vijgen, J. (2012) · Acta Cardiologica · doi:10.1080/ac.67.3.2160714 · Cited by 34
Screening for atrial fibrillation above age 65 detects an asymptomatic subset at high risk of stroke
Deif, B., Lowres, N., & Freedman, S. B. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.08.002 · Cited by 28
Self-citationLowres, N., Freedman, S. B., Redfern, J., McLachlan, A., Krass, I., Bennett, A., Briffa, T., Bauman, A., & Neubeck, L. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001355 · Cited by 23
Self-citation173 Silent atrial fibrillation in olmsted county: A community-based study
Tsang, T. S. M., Barnes, M. E., Pellikka, P. A., Gin, K. G., Miyasaka, Y., Seward, J. B., & Gersh, B. J. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.07.121 · Cited by 16
Assessing cardiovascular risk in regional areas: the Healthy Hearts – Beyond City Limits program
Carrington, M. J., Jennings, G., Clark, R. A., & Stewart, S. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-296 · Cited by 13
ADVERSE PROGNOSIS OF ASYMPTOMATIC ATRIAL FIBRILLATION DETECTED INCIDENTALLY: A CASE FOR SCREENING
Freedman, B., Katholing, A., & Martínez, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(13)60371-x · Cited by 3
Fog on the Crystal Ball? Missing Atrial Fibrillation in Forecasting the Future of Stroke
Neubeck, L., Orchard, J. J., & Freedman, S. B. (2013) · Stroke · doi:10.1161/strokeaha.113.002495 · Cited by 1
Self-citation
Research works printed but not linked: 2
- National Collaborating Centre for Chronic Conditions, 2006, Atrial fibrillation: national clinical guideline for management in primary and secondary care
- AS Vestergaard, 2013, A health economic evaluation of stroke prevention in atrial fibrillation – current treatment practice versus guideline adherence in Denmark [Masters Thesis]
Cited by
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Metadata
- Authors
- Lowres, N., Neubeck, L., Salkeld, G., Krass, I., McLachlan, A. J., Redfern, J., Bennett, A. A., Briffa, T., Bauman, A., Martinez, C., Wallenhorst, C., Lau, J. K., Brieger, D. B., Sy, R. W., & Freedman, S. B.
- Affiliations
- The University of Sydney (AU)
- The University of Western Australia (AU)
- ORCID
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2014
- Volume
- 111
- Issue
- 06
- Pages
- 1167-1176
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W1616073113
- Cited by
- 458
- References
- 48
- Citations by year
- 2026: 14 · 2025: 15 · 2024: 14 · 2023: 22 · 2022: 40 · 2021: 57 · 2020: 52 · 2019: 44 · 2018: 58 · 2017: 52 · 2016: 48 · 2015: 28 · 2014: 14
- FWCI
- 32.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thrombosis and Haemostasis (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Research Online (University of Wollongong) (submittedVersion)
- Edinburgh Napier Research Repository (Edinburgh Napier University) (submittedVersion)
- Funders
- Bristol-Myers Squibb/Pfizer
- Boehringer Ingelheim
- Bayer
- Career Development and Future Leader Fellowship
- NHMRC and National Heart Foundation (APP1061793)
- NHMRC early career fellow (APP1036763)
- National Heart Foundation Postgraduate Scholarship (PP12S6990)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- atrial fibrillation, stroke prevention, community-based screening, cost-effectiveness, thromboembolic risk, CHA2DS2-VASc score, older adults
- MeSH terms
- Aged, Aged, 80 and over, Algorithms, Atrial Fibrillation, Community Health Services, Cost-Benefit Analysis, Cross-Sectional Studies, Diagnosis, Computer-Assisted, Electrocardiography, Female, Humans, Male, Mass Screening, New South Wales, Pharmacies, Pharmacists, Prevalence, Quality-Adjusted Life Years, Stroke, Cell Phone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.